[123I] MNI-308
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [123I] MNI-308, covering 2009-08-21 to 2009-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC [Phase 1]